Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review

Kandice Ludwig, Joan Neuner, Annabelle Butler, Jennifer L. Geurts, Amanda L. Kong

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Background Mutations in BRCA1 or BRCA2 genes results in an elevated risk for developing both breast and ovarian cancers over the lifetime of affected carriers. General surgeons may be faced with questions about surgical risk reduction and survival benefit of prophylactic surgery. Methods A systematic literature review was performed using the electronic databases PubMed, OVID MEDLINE, and Scopus comparing prophylactic surgery vs observation with respect to breast and ovarian cancer risk reduction and mortality in BRCA mutation carriers. Results Bilateral risk-reducing mastectomy provides a 90% to 95% risk reduction in BRCA mutation carriers, although the data do not demonstrate improved mortality. The reduction in ovarian and breast cancer risks using risk-reducing bilateral salpingo-oophorectomy has translated to improvement in survival. Conclusions Clinical management of patients at increased risk for breast cancer requires consideration of risk, patient preference, and quality of life.

Original languageEnglish (US)
Pages (from-to)660-669
Number of pages10
JournalAmerican Journal of Surgery
Volume212
Issue number4
DOIs
StatePublished - Oct 1 2016

Fingerprint

Risk Reduction Behavior
Mutation
Survival
Ovarian Neoplasms
Breast Neoplasms
BRCA2 Gene
BRCA1 Gene
Mortality
Patient Preference
Mastectomy
Ovariectomy
PubMed
MEDLINE
Quality of Life
Observation
Databases

Keywords

  • BRCA
  • Mastectomy
  • Oophorectomy
  • Prophylactic
  • Risk reducing

ASJC Scopus subject areas

  • Surgery

Cite this

Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. / Ludwig, Kandice; Neuner, Joan; Butler, Annabelle; Geurts, Jennifer L.; Kong, Amanda L.

In: American Journal of Surgery, Vol. 212, No. 4, 01.10.2016, p. 660-669.

Research output: Contribution to journalArticle

Ludwig, Kandice ; Neuner, Joan ; Butler, Annabelle ; Geurts, Jennifer L. ; Kong, Amanda L. / Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. In: American Journal of Surgery. 2016 ; Vol. 212, No. 4. pp. 660-669.
@article{31c0e7ec720e44aeb9729a903033ce69,
title = "Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review",
abstract = "Background Mutations in BRCA1 or BRCA2 genes results in an elevated risk for developing both breast and ovarian cancers over the lifetime of affected carriers. General surgeons may be faced with questions about surgical risk reduction and survival benefit of prophylactic surgery. Methods A systematic literature review was performed using the electronic databases PubMed, OVID MEDLINE, and Scopus comparing prophylactic surgery vs observation with respect to breast and ovarian cancer risk reduction and mortality in BRCA mutation carriers. Results Bilateral risk-reducing mastectomy provides a 90{\%} to 95{\%} risk reduction in BRCA mutation carriers, although the data do not demonstrate improved mortality. The reduction in ovarian and breast cancer risks using risk-reducing bilateral salpingo-oophorectomy has translated to improvement in survival. Conclusions Clinical management of patients at increased risk for breast cancer requires consideration of risk, patient preference, and quality of life.",
keywords = "BRCA, Mastectomy, Oophorectomy, Prophylactic, Risk reducing",
author = "Kandice Ludwig and Joan Neuner and Annabelle Butler and Geurts, {Jennifer L.} and Kong, {Amanda L.}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.amjsurg.2016.06.010",
language = "English (US)",
volume = "212",
pages = "660--669",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review

AU - Ludwig, Kandice

AU - Neuner, Joan

AU - Butler, Annabelle

AU - Geurts, Jennifer L.

AU - Kong, Amanda L.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background Mutations in BRCA1 or BRCA2 genes results in an elevated risk for developing both breast and ovarian cancers over the lifetime of affected carriers. General surgeons may be faced with questions about surgical risk reduction and survival benefit of prophylactic surgery. Methods A systematic literature review was performed using the electronic databases PubMed, OVID MEDLINE, and Scopus comparing prophylactic surgery vs observation with respect to breast and ovarian cancer risk reduction and mortality in BRCA mutation carriers. Results Bilateral risk-reducing mastectomy provides a 90% to 95% risk reduction in BRCA mutation carriers, although the data do not demonstrate improved mortality. The reduction in ovarian and breast cancer risks using risk-reducing bilateral salpingo-oophorectomy has translated to improvement in survival. Conclusions Clinical management of patients at increased risk for breast cancer requires consideration of risk, patient preference, and quality of life.

AB - Background Mutations in BRCA1 or BRCA2 genes results in an elevated risk for developing both breast and ovarian cancers over the lifetime of affected carriers. General surgeons may be faced with questions about surgical risk reduction and survival benefit of prophylactic surgery. Methods A systematic literature review was performed using the electronic databases PubMed, OVID MEDLINE, and Scopus comparing prophylactic surgery vs observation with respect to breast and ovarian cancer risk reduction and mortality in BRCA mutation carriers. Results Bilateral risk-reducing mastectomy provides a 90% to 95% risk reduction in BRCA mutation carriers, although the data do not demonstrate improved mortality. The reduction in ovarian and breast cancer risks using risk-reducing bilateral salpingo-oophorectomy has translated to improvement in survival. Conclusions Clinical management of patients at increased risk for breast cancer requires consideration of risk, patient preference, and quality of life.

KW - BRCA

KW - Mastectomy

KW - Oophorectomy

KW - Prophylactic

KW - Risk reducing

UR - http://www.scopus.com/inward/record.url?scp=84991709374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991709374&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2016.06.010

DO - 10.1016/j.amjsurg.2016.06.010

M3 - Article

C2 - 27649974

AN - SCOPUS:84991709374

VL - 212

SP - 660

EP - 669

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 4

ER -